Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 4/20 | 0.34 |
| ▸ | PPARA | Q07869 | 4/20 | 0.34 |
| ▸ | LPL | P06858 | 2/20 | 0.32 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16747506 | 0.99 | PPARG (0.33) | PPARGPPARALPLLIPG | |
| SCHEMBL16747415 | 0.78 | HMGCR (0.43) | PPARGPPARALPLLIPG | |
| SCHEMBL16747538 | 0.76 | HMGCR (0.44) | PPARGPPARALPLLIPG | |
| SCHEMBL31529676 | 0.74 | LPL (0.51) | PPARGPPARALPLLIPG | |
| SCHEMBL16747498 | 0.74 | VDR (0.43) | PPARGPPARA | |
| SCHEMBL16747497 | 0.73 | VDR (0.42) | PPARGPPARA | |
| SCHEMBL16747507 | 0.72 | VDR (0.41) | PPARGPPARA | |
| SCHEMBL16747381 | 0.72 | VDR (0.44) | PPARGPPARA | |
| SCHEMBL16747383 | 0.71 | VDR (0.45) | PPARGPPARA | |
| SCHEMBL16747380 | 0.71 | VDR (0.44) | PPARGPPARALPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9663429-B2 | Vitamin D analogues of pharmaceutical interest | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2017-05-30 | — | — | US | disclosed |
| US-20160297731-A1 | VITAMIN D ANALOGUES OF PHARMACEUTICAL INTEREST | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2016-10-13 | — | — | US | disclosed |
| EP-3072873-A1 | VITAMIN D ANALOGUES OF PHARMACEUTICAL INTEREST | Universidade De Santiago De Compostela (ES) | 2016-09-28 | — | — | EP | disclosed |
| WO-2015075291-A1 | VITAMIN D ANALOGUES OF PHARMACEUTICAL INTEREST | UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (ES) | 2015-05-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160297731-A1 | VITAMIN D ANALOGUES OF PHARMACEUTICAL INTEREST | CYP24A1, VDR, CYP2R1 | PPARG 728/4885PPARA 613/4885LPL 2579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.